COVID-19 vaccination in the setting of mastocytosis-Pfizer-BioNTech mRNA vaccine is safe and well tolerated

被引：18
作者：
Lazarinis, Nikolaos [1 ,2 ]
Bossios, Apostolos [1 ,2 ]
Gulen, Theo [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Karolinska Univ Hosp Huddinge, Dept Resp Med & Allergy, K85, SE-14186 Stockholm, Sweden
[2] Karolinska Inst, Dept Med Huddinge, Stockholm, Sweden
[3] Karolinska Inst, Dept Med Solna, Clin Immunol & Allergy Unit, Stockholm, Sweden
[4] Karolinska Inst, Mastocytosis Ctr Karolinska, Stockholm, Sweden
[5] Karolinska Univ, Huddinge Hosp, Stockholm, Sweden
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE | 2022年 / 10卷 / 05期
关键词：
D O I：
10.1016/j.jaip.2022.01.037
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：1377 / 1379
页数：3
相关论文
共 9 条
[1]   COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM) [J].
Bonadonna, Patrizia ;
Brockow, Knut ;
Niedoszytko, Marek ;
Elberink, Hanneke Oude ;
Akin, Cem ;
Nedoszytko, Boguslaw ;
Butterfield, Joseph H. ;
Alvarez-Twose, Ivan ;
Sotlar, Karl ;
Schwaab, Juliana ;
Jawhar, Mohamad ;
Castells, Mariana ;
Sperr, Wolfgang R. ;
Hermine, Olivier ;
Gotlib, Jason ;
Zanotti, Roberta ;
Reiter, Andreas ;
Broesby-Olsen, Sigurd ;
Bindslev-Jensen, Carsten ;
Schwartz, Lawrence B. ;
Horny, Hans-Peter ;
Radia, Deepti ;
Triggiani, Massimo ;
Sabato, Vito ;
Carter, Melody C. ;
Siebenhaar, Frank ;
Orfao, Alberto ;
Grattan, Clive ;
Metcalfe, Dean D. ;
Arock, Michel ;
Gulen, Theo ;
Hartmann, Karin ;
Valent, Peter .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (06) :2139-2144
[2]   Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease [J].
Gulen, T. ;
Hagglund, H. ;
Dahlen, B. ;
Nilsson, G. .
JOURNAL OF INTERNAL MEDICINE, 2016, 279 (03) :211-228
[3]   High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience [J].
Gulen, T. ;
Hagglund, H. ;
Dahlen, B. ;
Nilsson, G. .
CLINICAL AND EXPERIMENTAL ALLERGY, 2014, 44 (01) :121-129
[4]   Venom immunotherapy in patients with clonal mast cell disorders: IgG4 correlates with protection [J].
Jarkvist, Jesper ;
Salehi, Clara ;
Akin, Cem ;
Gulen, Theo .
ALLERGY, 2020, 75 (01) :169-177
[5]   Safety of COVID-19 vaccination in patients with mastocytosis and monoclonal mast cell activation syndrome [J].
Kaakati, Rayan ;
Khokhar, Dilawar ;
Akin, Cem .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (08) :3198-3199
[6]   Safety of BNT162b2 mRNA COVID-19 vaccine in patients with mast cell disorders [J].
Rosman, Yossi ;
Lavi, Noa ;
Meir-Shafrir, Keren ;
Lachover-Roth, Idit ;
Cohen-Engler, Anat ;
Mekori, Yoseph A. ;
Confino-Cohen, Ronit .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (09) :3487-3489
[7]   Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk [J].
Shavit, Ronen ;
Maoz-Segal, Ramit ;
Iancovici-Kidon, Mona ;
Offengenden, Irena ;
Yahia, Soad Haj ;
Maayan, Diti Machnes ;
Lifshitz-Tunitsky, Yulia ;
Niznik, Stanley ;
Frizinsky, Shirly ;
Deutch, Michal ;
Elbaz, Eti ;
Genaim, Hosney ;
Rahav, Galia ;
Levy, Itzchak ;
Belkin, Anna ;
Regev-Yochay, Gili ;
Afek, Arnon ;
Agmon-Levin, Nancy .
JAMA NETWORK OPEN, 2021, 4 (08)
[8]  
Shimabukuro T, 2021, MMWR-MORBID MORTAL W, V70, P46, DOI [10.15585/mmwr.mm7002e1, 10.15585/mmwr.mm7004e1externalicon, 10.1111/ajt.16516]
[9]   Vaccination management in children and adults with mastocytosis [J].
Zanoni, G. ;
Zanotti, R. ;
Schena, D. ;
Sabbadini, C. ;
Opri, R. ;
Bonadonna, P. .
CLINICAL AND EXPERIMENTAL ALLERGY, 2017, 47 (04) :593-596
1